Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4–7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia–Reperfusion
Open accessThe DOI matches its Crossref record; 59 of the 64 references it cites were found in a registry or an index; 13 of the 39 sources its claims cite were checked for support.
Abstract
The Semax (Met-Glu-His-Phe-Pro-Gly-Pro) peptide is a synthetic melanocortin derivative that is used in the treatment of ischemic stroke. Previously, studies of the molecular mechanisms underlying the actions of Semax using models of cerebral ischemia in rats showed that the peptide enhanced the transcription of neurotrophins and their receptors and modulated the expression of genes involved in the immune response. A genome-wide RNA-Seq analysis revealed that, in the rat transient middle cerebral artery occlusion (tMCAO) model, Semax suppressed the expression of inflammatory genes and activated the expression of neurotransmitter genes. Here, we aimed to evaluate the effect of Semax in this model via the brain expression profiling of key proteins involved in inflammation and cell death processes (MMP-9, c-Fos, and JNK), as well as neuroprotection and recovery (CREB) in stroke. At 24 h after tMCAO, we observed the upregulation of active CREB in subcortical structures, including the focus of the ischemic damage; downregulation of MMP-9 and c-Fos in the adjacent frontoparietal cortex; and downregulation of active JNK in both tissues under the action of Semax. Moreover, a regulatory network was constructed. In conclusion, the suppression of inflammatory and cell death processes and the activation of recovery may contribute to the neuroprotective action of Semax at both the transcriptome and protein levels.
Overview
CoChat Summary
## TL;DR
In a rat transient middle cerebral artery occlusion (tMCAO) model, Semax altered protein and gene-expression markers in ways the authors interpret as neuroprotective at 24 h after ischemia–reperfusion. The main reported effects were decreased pJNK in both subcortex and cortex, increased pCREB in subcortex, and reduced MMP-9 and c-Fos in the adjacent frontoparietal cortex.
## Key findings
- At 24 h after tMCAO, ischemia–reperfusion increased pJNK by more than two-fold in both subcortex and cortex; Semax reduced pJNK by more than 1.5-fold.
- In the subcortex, ischemia reduced pCREB by more than 1.4-fold, and Semax increased pCREB by more than 1.5-fold; pCREB in cortex was unchanged by ischemia, and Semax caused a non-significant increase.
- In the cortex, IR increased MMP-9 and c-Fos protein levels by about two-fold; Semax decreased both by more than 1.5-fold. In the adjacent frontoparietal cortex, Semax also lowered Mmp9 mRNA by approximately 1.7-fold and Fos mRNA by 2.6-fold.
- The authors report that Semax did not significantly change MMP-9 or c-Fos in the subcortex, despite ischemia-related increases in MMP-9 there by approximately 1.7-fold.
## Methods
- Adult male Wistar rats (2-month-old, 200–250 g) underwent 90 min right middle cerebral artery occlusion under MRI control, followed by reperfusion; animals were sacrificed 24 h later.
- Groups included Semax-treated ischemia (100 μg/kg intraperitoneally immediately after occlusion and again at 1.5 and 5 h after reperfusion), saline-treated ischemia/reperfusion, and sham-operated controls; at least six animals were included per comparison for RT–PCR and 5–7 per group for protein analysis.
- The study used histology (H&E), Western blotting for pJNK, pCREB, MMP-9, c-Fos, and real-time RT–PCR for Mmp9 and Fos mRNA; statistics used Student’s t test and p < 0.05.
## Limitations
- The paper explicitly states that it analyzed the expression of only four proteins, and that genome-wide proteomic analysis might reveal additional proteins involved in the response to Semax.
- The text also makes evident that the study focused on a single time point (24 h after occlusion) and a rodent model, so the findings do not by themselves establish longer-term effects or human efficacy (evident from the study design, not stated as a limitation).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Scheme of JNK and CREB participation in the signaling pathways identified by us previously [17,22] and associated with ischemia–reperfusion and Semax action in the subcortical structures of the brain at 24 h after tMCAO. The network was constructed using the Cytoscape 3.7.0 program. The oval blocks at the nodes represent proteins. The gray rectangular boxes represent signaling pathways. The lines connecting the oval and rectangular blocks indicate the participation of the protein in the signaling pathway.](https://figures.cochat.ai/paper-figures/d123e042dd914c188ac191034817d17c/brain-protein-expression-profile-confirms-the-protective-effect-of-the-acth-47-figure-4.jpg)
Verification
Claims the paper makes
11 Valid · 0 Not valid · 15 Not checked · 48 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“significantly affects the expression of genes associated with the processes of the immune response [15,16]”
§ Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4–7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia–Reperfusion > 1. Introduction
What the sources say
- Supportedcites [15] Medvedeva, E.V., Dmitrieva, V.G., Povarova, O.V., Limborska, S.A., Skvortsova, V.I., Myasoedov, N.F., and Dergunova, L.V. (2014). The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: Genome-wide transcriptional analysis. BMC Genom., 15. source
The Conclusions state that Semax most markedly affected the immune response in rat brain cortical cells under experimental focal ischemia, enhancing chemokine and immunoglobulin gene expression. The Results also report altered gene expression in ischemia-damaged rat brain cortex after Semax administration. Page numbers were not provided in our copy. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [16] Medvedeva, 2017, Semax, an analog of ACTH(4-7), regulates expression of immune response genes during ischemic brain injury in rats, Mol. Genet. Genom. source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“it enhances the transcription of neurotrophins and their receptors [13,14]”
§ Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4–7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia–Reperfusion > 1. Introduction
What the sources say
- Supportedcites [13] Dmitrieva, 2010, Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia, Cell. Mol. Neurobiol. source
The Discussion reports that Semax upregulated transcription of neurotrophins and their receptors in the ischemic cortex of rats after occlusion. It identifies increases in Bdnf, TrkA, and TrkC mRNA at 3 hours and Nt-3 and Ngf mRNA at 24 hours, supporting the attributed claim. (LLM, conf=0.94)
- Not checked — no full text of the sourcecites [14] Stavchansky, 2011, The effect of Semax and its C-end peptide PGP on the morphology and proliferative activity of rat brain cells during experimental ischemia: A pilot study, J. Mol. Neurosci. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“It should be noted that CREB activation and JNK inhibition are involved in the anti-inflammatory and neuroprotective action of melanocortins in models of ischemic and inflammatory processes in the brain [4,60].”
§ Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4–7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia–Reperfusion > 5. Conclusions
What the sources say
- Not checked yetcites [4] Mykicki, 2016, Melanocortin-1 receptor activation is neuroprotective in mouse models of neuroinflammatory disease, Sci. Transl. Med. source
Checked before — its earlier verdict is held back until a new check runs.
- Partly supportedcites [60] Chen, S., Zhao, L., Sherchan, P., Ding, Y., Yu, J., Nowrangi, D., Tang, J., Xia, Y., and Zhang, J.H. (2018). Activation of melanocortin receptor 4 with RO27-3225 attenuates neuroinflammation through AMPK/JNK/p38 MAPK pathway after intracerebral hemorrhage in mice. J. Neuroinflammation, 15. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports that RO27-3225 reduced phosphorylated JNK and inflammatory cytokines and improved neurobehavioral outcomes after intracerebral hemorrhage in mice. The Background also discusses protective effects in cerebral ischemia, but the paper does not identify CREB activation as a mechanism; its proposed pathway involves AMPK, JNK, and p38 MAPK. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not checked yet
Every source the paper cites for this claim was checked and supports it.
In the paper
“We have previously shown that, in the subcortical structures of the brain containing the focus of ischemic damage, Semax initiates a large-scale neurotransmitter and anti-inflammatory response that counteracts ischemia–reperfusion [17].”
§ Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4–7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia–Reperfusion > 3. Discussion
What the sources say
- Supportedcites [17] Filippenkov, I.B., Stavchansky, V.V., Denisova, A.E., Yuzhakov, V.V., Sevan’kaeva, L.E., Sudarkina, O.Y., Dmitrieva, V.G., Gubsky, L.V., Myasoedov, N.F., and Limborska, S.A. (2020). Novel insights into the protective properties of acth(4-7)pgp (semax) peptide at the transcriptome level following cerebral ischaemia– reperfusion in rats. Genes, 11. source
The Conclusions report that, in subcortical brain tissue under transient ischemia–reperfusion conditions, Semax suppressed inflammatory genes and activated neurotransmitter genes, counteracting the expression changes caused by ischemia–reperfusion. The Discussion describes this as an effect on several hundred genes; the response measured was at the transcriptome level. (LLM, conf=0.91)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“At 24 h after tMCAO, we observed the upregulation of active CREB in subcortical structures, including the focus of the ischemic damage”
- Also stated in: § 2.2. Changes in the Levels of pJNK, pCREB, MMP-9, and c-Fos in the Subcortical Structures and Cortex of the Rat Brain under the Conditions of Ischemia–Reperfusion · plain
“whereas Semax increased its levels by more than 1.5-fold (Figure 2c).”
- Also stated in: § 3. Discussion · plain
“In our experiment, a decrease in the level of pCREB was detected under the conditions of ischemia–reperfusion in the subcortical structures of the brain at 24 h after the onset of occlusion, which was completely rescued by Semax.”
§ Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4–7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia–Reperfusion > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 2.2. Changes in the Levels of pJNK, pCREB, MMP-9, and c-Fos in the Subcortical Structures and Cortex of the Rat Brain under the Conditions of Ischemia–Reperfusion · plain
36 more claims
Create a free account to see all 74 claims and to verify the 7 references still open.
- It may state two separate claims as one. 21
- Probably not a substantial claim. 16
Citations
Cites
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888 · cited 2×
“The use of the Cytoscape 3.7.0 program (Institute for Systems Biology, Seattle, WA, USA) [23] based on the data of the association of differentially expressed genes with functional annotations allowed us to illustrate the participation of pJNK and pCREB in the signaling pathways that exhibited changes in their activit…”
BackgroundInfluentialSingle-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426 · cited 1×
“The total RNA from the subcortex, was isolated using TRI Reagent (MRC, Cincinnati, OH, USA) and acid guanidinium thiocyanate–phenol– chloroform extraction [51].”
MethodThe MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments
Bustin, S. A., Benes, V., Garson, J. A., Hellemans, J., Huggett, J., Kubista, M., Mueller, R., Nolan, T., Pfaffl, M. W., Shipley, G. L., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.112797 · Cited by 16,303 · cited 1×
“Two reference genes, Gapdh and Rpl3, were used to normalize the cDNA samples [52].”
MethodPfaffl, M. W. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.9.e36 · Cited by 7,376 · cited 1×
“Calculations were performed using BestKeeper, version 1 [53] and Relative Expression Software Tool (REST) 2005 software (gene-quantification, Freising-Weihenstephan, Bavaria, Germany) [54].”
MethodPfaffl, M. W., Tichopad, A., Prgomet, C., & Neuvians, T. P. (2004) · Biotechnology Letters · doi:10.1023/b:bile.0000019559.84305.47 · Cited by 5,065 · cited 2×
“The PCR efficiencies were assessed using the amplification of a series of standard dilutions of cDNAs and computed using REST software [54].”
MethodIschemic Cell Death in Brain Neurons
Lipton, P. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1431 · Cited by 3,043
A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia
Borsello, T., Clarke, P. G. H., Hirt, L., Vercelli, A., Repici, M., Schorderet, D. F., Bogousslavsky, J., & Bonny, C. (2003) · Nature Medicine · doi:10.1038/nm911 · Cited by 658 · cited 1×
“These data are in good agreement with the results of studies that showed an increase in JNK phosphorylation and in the activity of the JNK signaling pathway in the brains of rodents after ischemia [36].”
ResultTargeting JNK for therapeutic benefit: from junk to gold?
Manning, A. M., & Davis, R. J. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1132 · Cited by 585 · cited 1×
“Phosphorylated JNK (pJNK) alters the activity of many proteins, including the activation of the transcription factors c-JUN, ATF2, and SP-1 [29].”
BackgroundSpreading Depression, Spreading Depolarizations, and the Cerebral Vasculature
Ayata, C., & Lauritzen, M. (2015) · Physiological Reviews · doi:10.1152/physrev.00027.2014 · Cited by 555
Sakamoto, K., Karelina, K., & Obrietan, K. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07080.x · Cited by 543 · cited 1×
“Unlike MMP-9, pJNK, and c-Fos, the phosphorylated form of the CREB transcription factor (pCREB) regulates the transcriptional programs of synaptic plasticity, neurogenesis, and neuronal survival in the brain [37].”
Background
Research works printed but not linked: 3
- Paxinos, G., and Watson, C. (2007). The Rat Brain in Stereotaxic Coordinates, Academic Press. [6th ed.].
- (2021, May 25). National Center for Biotechnology Information, Available online: https://www.ncbi.nlm.nih.gov/sra/PRJNA491404.
- (2021, May 25). National Center for Biotechnology Information, Available online: https://www.ncbi.nlm.nih.gov/Traces/study/?acc=SRP148632.
Cited by
Translational advances of melanocortin drugs: Integrating biology, chemistry and genetics
Montero‐Melendez, T., Boesen, T. P., & Jonassen, T. E. N. (2022) · Seminars in Immunology · doi:10.1016/j.smim.2022.101603 · Cited by 38
Differential gene expression in the contralateral hemisphere of the rat brain after focal ischemia
Filippenkov, I. B., Remizova, J. A., Denisova, A. E., Stavchansky, V. V., Golovina, K. D., Gubsky, L. V., Limborska, S. A., & Dergunova, L. V. (2023) · Scientific Reports · doi:10.1038/s41598-023-27663-8 · Cited by 20
Self-citationFilippenkov, I. B., Stavchansky, V. V., Denisova, A. E., Valieva, L. V., Remizova, J. A., Mozgovoy, I. V., Zaytceva, E. I., Gubsky, L. V., Limborska, S. A., & Dergunova, L. V. (2021) · Genes · doi:10.3390/genes12121870 · Cited by 18
“Additionally the brain expression profiling of key proteins involved in inflammation and cell death processes (MMP-9, c-Fos, and JNK), as well as neuroprotection and recovery (CREB) was revealed at 24 h after tMCAO [31].”
BackgroundSelf-citationFan, X., Shi, G., Zhao, Y., Yang, J.-J., & Feng, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115520 · Cited by 17
Filippenkov, I. B., Remizova, J. A., Denisova, A. E., Stavchansky, V. V., Golovina, K. D., Gubsky, L. V., Limborska, S. A., & Dergunova, L. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137308 · Cited by 13
“Moreover, previously, we reported the brain expression profile of key proteins involved in inflammation and cell death processes (MMP-9, c-Fos, and JNK), as well as in neuroprotection and recovery (CREB), as detected at 24 h after tMCAO in the IH [13].”
BackgroundSelf-citation
Metadata
- Authors
- Sudarkina, O. Y., Filippenkov, I. B., Stavchansky, V. V., Denisova, A. E., Yuzhakov, V. V., Sevan’kaeva, L. E., Valieva, L. V., Remizova, J. A., Dmitrieva, V. G., Gubsky, L. V., Myasoedov, N. F., Limborska, S. A., & Dergunova, L. V.
- Affiliations
- Kurchatov Institute (RU)
- Pirogov Russian National Research Medical University (RU)
- Ministry of Health of the Russian Federation (RU)
- Corresponding author
- Sudarkina, Olga Yu.
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-06-08
- Volume
- 22
- Issue
- 12
- Pages
- 6179
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8226508
- OpenAlex
- W3166937788
- Cited by
- 15
- References
- 64
- Citations by year
- 2025: 4 · 2024: 2 · 2023: 4 · 2022: 4 · 2021: 1
- FWCI
- 1.10
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Russian Science Foundation (19-14-00268)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- Semax, cerebral ischemia-reperfusion injury, ischemic stroke, neuroprotection, transient middle cerebral artery occlusion, brain protein expression, CREB, MMP-9, c-fos, JNK, neuroinflammation, cell death, gene regulatory networks
- MeSH terms
- RNA-Seq, Adrenocorticotropic Hormone, Animals, Brain, Brain Ischemia, Disease Models, Animal, Male, Peptide Fragments, Reperfusion Injury, Rats, Wistar, Neuroprotective Agents, Proteome, Rats, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4–7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia–Reperfusion. https://app.cochat.ai/papers/10.3390/ijms22126179
- The paper
- Sudarkina, O. Y., Filippenkov, I. B., Stavchansky, V. V., Denisova, A. E., Yuzhakov, V. V., Sevan’kaeva, L. E., Valieva, L. V., Remizova, J. A., Dmitrieva, V. G., Gubsky, L. V., Myasoedov, N. F., Limborska, S. A., & Dergunova, L. V. (2021). Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4–7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia–Reperfusion. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms22126179
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.